New Drug Applications News
-
Pfizer launches Rimegepant in Singapore for Acute and Prophylactic Migraine relief
New Drug Applications | News | 0 Comment | 31 Jan, 2024
Pfizer’s NURTEC® (rimegepant), an orally disintegrating tablet for both the acute treatment of migraine is now...Read more
-
Junshi Biosciences, Dr. Reddy’s to develop and commercialise oncology drug in 21 countries
New Drug Applications | News | 3 Comment | 08 May, 2023
Shanghai Junshi Biosciences Co. has collaborated with Indian pharmaceutical firm Dr. Reddy’s Laboratories to devel...Read more
-
Monoclonal antibody drug by GSK Singapore approved to treat chronic rhinosinusitis
New Drug Applications | News | 0 Comment | 07 Feb, 2023
GSK Singapore announced that Nucala (mepolizumab), a monoclonal antibody that targets interleukin-5 (IL-5...Read more
-
China approves first and only therapy available for patients with EGFR Exon20 Insertion+ NSCLC
New Drug Applications | News | 0 Comment | 12 Jan, 2023
Japan headquatered Takeda's EXKIVITY (mobocertinib) has been approved by the National Medical Products Administration (N...Read more
-
New Drug Applications | Analysis | 0 Comment | 20 Dec, 2022
The current diabetic neuropathic pain treatment paradigm includes many established analgesics that provide sym...Read more
-
Singapore paves the way for improved treatment of Alzheimer’s disease
New Drug Applications | News | 0 Comment | 06 Dec, 2022
A major clinical trial of an antibody treatment may soon pave the way for improved treatment of Alzheimer’s diseas...Read more
-
Huadong becomes strategic partner in Asia for Heidelberg Pharma, strikes deal worth $0.9B
New Drug Applications | News | 0 Comment | 01 Mar, 2022
German firm Heidelberg Pharma AG and Huadong Medicine in China have entered into a strategic partner...Read more
-
Japan to commercialize next-gen Hunter Syndrome therapy
New Drug Applications | News | 0 Comment | 01 Oct, 2021
Japanese firms Takeda Pharmaceutical Company and JCR Pharmaceuticals have announced a geographically-focused exclusive c...Read more
-
US approves first ophthalmology biosimilar, developed by South Korea
New Drug Applications | News | 0 Comment | 23 Sep, 2021
South Korea-based Samsung Bioepis has announced that the US Food and Drug Administration (FDA) has approved BYOOVIZ...Read more
-
Japan sets eyes on rare pediatric liver diseases
New Drug Applications | News | 0 Comment | 22 Sep, 2021
US-based Mirum Pharmaceuticals, Inc. and Japanese firm Takeda Pharmaceutical have entered into an exclusive licensing ag...Read more
-
Australia approves novel therapy to treat Advanced Small Cell Lung Cancer
New Drug Applications | News | 0 Comment | 15 Sep, 2021
Australian patients with an aggressive form of lung cancer (metastatic Small Cell Lung Cancer) can now access a new...Read more
-
Eli Lilly Japan, Daiichi Sankyo ink pact to commercialise migraine drug
New Drug Applications | News | 0 Comment | 01 Sep, 2021
Eli Lilly Japan and Daiichi Sankyo Company have concluded an agreement on commercialisation collaboration in Japan for t...Read more
-
Japan to distribute hyperuricemia drug in five ASEAN countries
New Drug Applications | News | 0 Comment | 31 Aug, 2021
Japan-based Eisai and FUJI YAKUHIN have inked a license agreement concerning dotinurad (generic name), a treatment for h...Read more
-
Menarini to commercialize Japanese drug in Singapore, Malaysia, and the Philippines
New Drug Applications | News | 0 Comment | 23 Aug, 2021
Singapore-based Menarini Asia-Pacific Holdings, a part of the leading Italian global biopharmaceutical company Menarini ...Read more
-
UK's NICE recommends abemaciclib for advanced breast cancer
New Drug Applications | News | 0 Comment | 13 Aug, 2021
The UK National Institute for Health and Care Excellence (NICE) has published new draft guidance which recommends Eli Li...Read more
-
FDA approves combination therapy for Advanced Renal Cell Carcinoma (RCC)
New Drug Applications | News | 0 Comment | 12 Aug, 2021
U.S. Food and Drug Administration (FDA) has approved a combination therapy from Eisai and Merck (MSD) namely,&...Read more
-
Yuyu Pharma to distribute Novartis Korea's prescription medicines
New Drug Applications | News | 0 Comment | 04 Aug, 2021
Yuyu Pharma and Novartis Korea have entered into an agreement in which Yuyu will have exclusive distribution rights for ...Read more
-
FDA approves Medtronic's Artificial Intelligence Algorithms for Cardiac Monitoring
New Drug Applications | News | 0 Comment | 29 Jul, 2021
Medtronic, (headquartered in Dublin, Ireland), the global leader in medical technology, announced U.S. Food and Dru...Read more
